Brief: Galapagos NV Says Board Receives Non-Binding Offers For Cell Therapy Business
Oct 1 (Reuters) - Galapagos NV GLPG.AS: GALAPAGOS PROVIDES UPDATE ON STRATEGIC ALTERNATIVES FOR ITS CELL THERAPY BUSINESS GALAPAGOS NV - BOARD RECEIVES NON-BINDING OFFERS FOR CELL THERAPY BUSINESS GALAPAGOS NV - ANNOUNCEMENT ON CELL THERAPY STRATEGIC REVIEW EXPECTED BY NOV 5 GALAPAGOS NV: NON-BINDING OFFERS WERE FROM CONSORTIA, PREDOMINANTLY COMPRISED OF FINANCIAL INVESTORS, TO ACQUIRE CELL THERAPY BUSINESS Source text: ID:nGNXpsRtj Further company coverage: GLPG.AS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline